Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
165,166 Retatrutide has now entered Phase III clinical trials
In a study of 3,731 patients assigned to take either liraglutide or placebo, 63.2% of patients taking liraglutide lost at least 5% of their body weight and 33.1% of patients lost at least 10% of their body weight
However, most patients do not experience serious symptoms, with one study showing only 4% of patients experienced intense diarrhea
For a GLP-1 program to succeed in the long term, we include simple nutritional coaching
it is only accessible through authorised Phase 3 clinical trials, with NHS availability subject to future regulatory and NICE assessment
Chemical and Identification Data Molecular formula: C 221 H 342 N 46 O 68 Molecular weight: 4860 g/mol CAS number: 2381089-83-2 PubChem CID: 171390338 DrugBank ID: DB18993 Summary Are you looking to buy retatrutide in the UK
US$ 25.01
US$ 27.67
US$ 22.99
